Ausgabe 2/1999
Inhalt (10 Artikel)
Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM)
Maria-Christina Kyrtsonis, Athanasia Mouzaki, Alice Maniatis
Cancer gene and immunotherapy: recent developments
Peter Jantscheff, Richard Herrmann, Christoph Rochlitz
Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population
Adnan A Ezzat, Ezzeldin M Ibrahim, Madras A Raja, Saif Al-Sobhi, Assem Rostom, Robert K Stuart
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis
Morie A Gertz, Martha Q Lacy, John A Lust, Philip R Greipp, Thomas E Witzig, Robert A Kyle
Transforming growth factor-β and multidrug resistance in chronic lymphocytic leukemia
William R Friedenberg, Sherry A Salzman, Sonja M Phan, James K Burmester
Assessment ofall-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia
Nalini Swaminathan, Gabriel Lopez-Berestein, Stuart Rudikoff
Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?
N Campanella, A Moraca, M Pergolini, W Daher, A Fianchini, A Sabbatini, A Brunelli, M Al-Refai
Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney
Dilek Dinçol, Ali Arican, Arzu Ensari, Serdar Akyar, Yaşar Bedük, Abdülkadir Cengiz
Hepatosplenic candidiasis after neutropenic phase of acute leukaemia
M Čolović, V Lazarević, R Čolović, G Janković, N Suvajdžić, A Bogdanović, J Bila